Andrew C.

Andrew C. is an Associate at Research Bridge Partners, where Andrew works on formative investments in biomedical startup companies. Andrew is also the Co-Founder/CEO of ImmunoScope, a biotech company focused on advancing precision immunology. Previously, Andrew has held roles such as Venture Fellow at Health Innovation Capital and Co-Director of Communications at Nucleate. Their background includes being a Doctoral Candidate and Researcher at UT Southwestern Medical Center, where Andrew developed machine learning tools for hematology-oncology. Andrew holds a Ph.D. in Computational Biology from UT Southwestern Medical Center, a Master of Science in Molecular Biology from Baylor University, and a Bachelor of Science in Molecular Biology from the University of Arkansas.